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Abstract 
BACKGROUND: Chronic rhinosinusitis with polyps (CRSwNP) have a high risk of recurrence and patients often 
experience repeated surgery. There are several types of inflammatory patterns in CRSwNP, such as Th2 
inflammation (eosinophilic) and Th1/Th17 inflammation (neutrophilic). 
AIM: This study aims to determine the expression of IL-5, IL-8, IL-17A and TGF-β in recurrent CRSwNP using the 
most convenient and non-invasive examination tool such as brushing the mucosal polyp and find out its 
correlation with polyp tissues. 
MATERIAL AND METHODS: A cross-sectional comparative study was carried out on 15 samples of mucosal 
brushing and polyp tissue. Expressions of IL-5, IL-8, IL-17A and TGF-β on mucosa were measured using the 
Enzyme-Linked Immunosorbent Assay (ELISA) examination and tissues using Immunohistochemical (IHC) 
examination. 
RESULT: The result showed that Only IL-5 has a significant relationship between mucosa and tissue with 
moderate positive correlation (p < 0.05; r = 0.527). 
CONCLUSION: This study concluded that mucosa brushing could be used as a simple and non-invasive 
examination to observe the expression of IL-5 in recurrent CRSwNP. IL-5 is one of the cytokines that mark the 
Th2 (eosinophilic) inflammatory pattern where eosinophilic polyps are closely related to recurrence. 
 
 
 
 
 
 
 
 
Introduction 
 
Chronic rhinosinusitis with polyps (CRS) is a 
chronic inflammatory disease of the sinuses and 
paranasal sinuses that last for more than 12 weeks, 
CRS can be accompanied by polyps (CRSwNP) or 
without polyps (CRSsNP) [1], [2]. This disease could 
reduce the quality of life of patients and cause an 
economic burden because of the high cost of 
treatment, especially because of the high rate of 
recurrence, causing patients to experience repeated 
surgery [3], [4], [5]. In the United States, chronic 
rhinosinusitis accounts for almost 16% of adults per 
year, which consumes health funds of around 5.8 
billion US/year [6]. The prevalence of CRS in 
Indonesia is quite high. Based on data from the ENT 
polyclinic at M. Djamil Central Public Hospital, Padang 
from October 2011 to September 2012, 106 new 
cases of CRS were found in which 87 cases were 
CRSWNP without polyps and 19 cases of CRSwNP. 
 There have been many theories and 
research, the exact aetiology of nasal polyps and the 
causes of recurrence is still unknown [6]. The role of 
several mediators (cytokines) such as interleukin, 
growth factors and chemokines in the inflammatory 
process had been widely investigated. In addition, the 
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effect of a combination of cytokines, which serves as 
a signal to the cell to provide response and growth 
factors, produced by T lymphocytes, fibroblasts, 
epithelial cells such as the Granulocyte Macrophage 
Colony Stimulating Factor (GM-CSF), Interleukin-3 
(IL-3) and Interleukin-5 (IL-5) plays an important role 
in the formation of polyps [7].  
Several recent studies have reported that 
there were differences in CRS immunoprofile between 
Caucasian and Asian races. The American and 
European populations have Th2 inflammatory pattern 
(eosinophilic inflammation) whereas in the Asian 
population have Th1/Th17 inflammatory pattern 
(neutrophilic inflammation [3], [8], [9]. 
The differences in histological and 
inflammatory patterns between CRSwNP in the 
Caucasians and Asians and the high recurrence rate 
of CRSwNP require further study to find out a 
comfortable and non-invasive examination tool that 
can detect polyps early. We hope the polyp can be 
diagnosed early without having to go through a 
polypectomy that makes the CRSwNP patient 
uncomfortable and spend more cost for treatment, 
such as brushing the mucosa of the polyp. Based on 
that, we will study the correlation of cytokine 
expression (IL-5, IL-8, IL-17A, and TGF-1) in 
CRSwNP recurrence between mucosa (brushing) and 
tissue (biopsy) of nasal polyps. 
 
 
Material and Methods 
 
Sample 
Samples obtained from CRSwNP patients 
who visited the Ear, Nose and Throat (ENT) clinic in 
the Public Central Hospital Dr M Djamil Padang and 
several hospitals in West Sumatera on August 2016 
until September 2018. A total of 15 CRSwNP patients 
met the inclusion and exclusion criteria in this study. 
Research approval was requested from the 
respondent before the operation. Samples were taken 
from CRSwNP patients who did not use anti-allergic 
drugs during the wash out period before brushing 
(chlorpheniramine for 3 days, cetirizine, fexofenadine, 
loratadine for 5 days each and corticosteroids for 2 
weeks) and aged between 18 and 55 years. 
 
Sampling 
Brushing performed on nasal polyps mucosa 
with the nasoendoscopy in a circular motion by using 
a modified gynecologic cytology brush. Before 
brushing the polyp, a cotton tampon containing 
lidocaine and adrenaline installed with a ratio of 4:1 
for 10 minutes on the nasal cavity. Brushing was done 
on the mucosa of the polyp in a circular motion ten 
times clockwise. Samples obtained from brushing 
were inserted into a sterile bottle containing PBS 
liquid and immediately taken to the Biomedical 
laboratory in the Faculty of Medicine, Andalas 
University and stored at a temperature of -80°C. 
Retrieval of nasal polyp tissue is performed 
during surgical removal of the polyp by FESS 
(Functional Endoscopy Sinus Surgery). Polyp tissue 
samples when FESS performed were put into neutral 
formalin liquid and immediately taken to the Anatomy 
Pathology Laboratory of the Andalas University 
Medical School to make paraffin blocks.  
 
ELISA 
In this research, human IL-5, IL-17 and TGF-
β1 were used from R&D and human IL-8 from BT lab 
for examines nasal mucous polyps. 
 
IHC 
Immunohistochemical staining techniques 
using the Labeled Streptavidin-Biotin Complex (LSAB) 
method were carried out by manual procedure. The 
results in the form of preparations were measured and 
calculated by looking under a microscope to assess 
the expression of IL-5, IL-8, IL-17, and TGF-β1. In this 
study, IL-5 (GeneTex) antibodies were used as 
polyclonal IgG from rabbits. Positive values are the 
results of assessments of the brown intensity of 
epithelium and stroma seen in the light microscope. 
 
Statistical Method 
We use SPSS program version 17.0.0.0. The 
analysis aimed to determine the correlation of IL-5, IL-
8, IL-17A, and TGF-β1 between tissue (IHC) and 
mucosa (ELISA) in recurrent CRSwNP.  
 
 
Results 
 
Research had been conducted on 30 samples 
from 15 CRSwNP patients who underwent FESS 
surgery for the second time. This study aims to 
determine the correlation of the expression of 
inflammation mediators between tissue and mucosa in 
recurrent CRSwNP. The clinical characteristics of 
CRSwNP patients can be seen in the table below. 
Table 1: Characteristics of respondents based on gender and 
age 
Characteristics Recurrent CRSWNP (n = 15) 
Sex 
Male 
 
12 (80%) 
Female 3 (20%) 
Age 41.40 ± 10.23 
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In Table 1, the percentage of males was 
higher than that of women; there were 12 male 
respondents and 3 female respondents with a ratio of 
4:1. The average age in the recurring CRSwNP group 
was 41.40 ± 10.23. 
 
Expression of IL-5, IL-8, IL-17, and TGF-β1 
 between mucosa and recurrent polyp 
 tissue 
The mean expression of IL-5 on the mucosa 
of recurrent CRSwNP was 2.75 (± 2.02) while the 
tissue was 78.80 (± 15.01).  
 
Figure 1: Expression of IL-5, IL-8, IL-17, and TGF-β1 mucosa with 
ELISA (pg/dl) in recurrent CRSwNP showed in the box plot graphs 
 
In figure 1, IL-5 was the only cytokine that had 
a significant correlation with moderate positive 
correlation; it can be concluded that the enhancement 
of expression of IL-5 in the mucosa accompanied by 
an increase of the expression of IL-5 in the tissue (p < 
0.05; r = 0.527). The mean of IL-8 in the mucosa was 
304.35 (± 34.86) while in the tissue was 78.33% (± 
18.79), but there was no significant correlation found 
(p > 0.05).  
 
Figure 2: The box plot of expression of IL-5, IL-8, IL-17, and TGF-
β1 tissue with IHC (per 100 cells) in recurrent CRSwNP tissue 
 
Like IL-8, IL-17A also did not have a 
significant correlation, the mean mucosa was 20.13 (± 
16.78), and the tissue was 77.13% (± 29.64). The 
mean of TGF-β1 in the recurrent mucosal CRSwNP 
was obtained at 24.51 (317.03) while the tissue was 
85.33% (± 12.38) with a non-significant correlation (p 
> 0.05). 
 
 
Figure 3: Correlation of expression of IL-5, IL-8, IL-17, and TGF-β1 
between mucosa and tissue in CRSwNP recurrent polyps 
 
 Of all the cytokines examined, only IL-5 had a 
significant correlation with a moderate positive 
correlation (p < 0.05; r = 0.527). 
 
Figure 4: Description of cell expression that produces cytokines in 
recurrent CRSwNP tissue with 40 X 10 enlargement: a) description 
of IL-5 expression; b) description of IL-8 expression; c) description 
of IL-17A expression; d) description of TGF-β1 expression. Red 
arrows indicate cells that contain positive cytokines 
 
 
Discussion 
 
Interleukin-5 in the mucosa and recurrent 
tissue CRSWNP has a significant relationship (p < 
0.05) with a moderate positive correlation (r = 0.527), 
we can conclude that the enhancement of expression 
IL-8 Tissue TGF Tissue 
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of IL-5 in the mucosa accompanied by an increase of 
the expression of IL-5 in the tissue. Interleukin-5 is a 
cytokine produced by T helper 2 (Th2) and ILC2 cells, 
which is important in the differentiation, maturation, 
toxicity, activation and survival of eosinophil [10], [11]. 
Interleukin-5, together with CCL11 (eotaxin) mobilises 
eosinophils into the tissues. Interleukin-5 stimulates 
eosinophils to increase its defence and cytotoxicity. 
Eosinophil infiltration and granulation encourage to 
release the toxic products such as major basic 
protein, eosinophil cationic protein, an eosinophil-
derived neurotoxin and eosinophil peroxidase which 
contribute to airway epithelial damage, mucus 
hypersecretion of goblet cells, and ciliary movement 
damage [12]. In a study conducted by Bachert, in 
immunohistochemical examination 70% of cells 
containing IL-5 were eosinophils, and there was a 
strong relationship between IL-5 and Eosinophilic 
Cationic Protein (ECP) which is a marker of eosinophil 
activation [10]. 
Many studies have reported that eosinophilic 
type CRSwNP has a worse recurrence and prognosis 
rate. Matsuwaki compared the neutrophilic type with 
eosinophilic type in 2008. Matsuwaki reported that 
patients with eosinophilic mucosa showed a high 
incidence of recurrence in 5 years, where the positive 
predictive value for recurrence was 85.7% [13]. 
Nakayama also reported that the presence of 
eosinophilic mucosa is often associated with disease 
severity and recurrence of nasal polyps [14]. Ikeda in 
2013 compared eosinophilic CRSWNP and 
neutrophilic CRSWNP types, found that eosinophilic 
type of CRSWNP had a poor prognosis of the disease 
and higher recurrence, especially eosinophilic 
CRSWNP with aspirin intolerance [15]. Similar was 
also reported by Tecimer in 2014 in which the study 
reported a higher recurrence rate in eosinophilic nasal 
polyps (55%) compared with neutrophilic nasal polyps 
(42.8%) [16]. Van Zele reported that the type of Th2 
inflammation and eosinophilic inflammation are the 
main risk factors for recurrence and the severity of the 
disease [3]. A study conducted by Lou in 2015 in the 
Chinese population, also reported that the proportion 
of tissue eosinophilia over 27% of total tissue cells 
could predict recurrence in nasal polyps with a 
sensitivity of 87.4% and specificity of 97.1% [17]. 
Histologically, Gevaert reported in 2004 that 
eosinophils were localised in blood vessels, borders, 
and just below the mucosal epithelium where mast 
cells were generally granulated and were found 
increased in the nasal polyp stroma. The 
enhancement of plasma cells and lymphocytes are 
also found on cellular levels [18]. The positive 
correlation in this study proved that in CRSwNP 
recurrence, the examination of IL-5 by brushing 
technique on the mucosa could be assessed with IL-5 
on the tissue so that the techniques can be used to 
look expression of IL-5 in early developmental of 
CRSwNP and can predict the possibility of recurrence. 
The mean expression of IL-8 on the mucosal 
CRSwNP recurrent is 304.35 (± 34.86) and in the 
tissues 78.33% (± 18.79) but there was no significant 
relationship between tissue and mucosa (p > 0.05). 
Interleukin-8 is an inflammatory cytokine that has 
strong neutrophil chemotaxis activity and can induce 
degranulation, respiratory burst, adherence, 
deformation, Ca2 + mobilisation and increased 
regulation of CD11b/CD18 neutrophils. The initial 
phase of interleukin-8 will be secreted mainly from 
glandular cells and epithelial cells. These cells tend to 
secrete IL-8 to attract neutrophils out of the mucosa to 
the luminal side, and neutrophils that have migrated 
can also secrete IL-8 resulting in positive feedback 
[19]. Besides neutrophils, IL-8 is also a chemokine 
that is very important for eosinophils in all types of 
CRSwNP and nasal polyps [20]. In the Asian 
population, CRSWNP polyps occur largely influenced 
by infectious factors where at the onset of CRSwNP 
polyps the amount of IL-8 is needed for mobilisation of 
inflammatory cells such as neutrophils and 
eosinophils to the nasal polyp CRS site [21], [22]. In 
recurrent CRSwNP, the role of IL-5 is more dominant 
where IL-5 plays a role in the differentiation, 
maturation and survival of eosinophils, which are 
important in the growth and recurrence of polyps. 
In this study, IL-17 expression in the mucosa 
was 20.13 (± 16.78), while in the tissue was 77.13% 
(± 29.64). Interleukin-17 is produced by cells induced 
by proinflammatory cytokines (such as IL-1, IL-6 and 
TNF-), chemokines (CXCL1, CXCL2, CXCL5 and 
CXCL8), and adhesive molecules (ICAM-1 and 
VCAM-1) [24]. The main source of IL-17 in nasal 
polyps is lymphocytes. Interleukin-17 can modulate 
the life of neutrophils in nasal polyps that are not 
cystic fibrosis. In the study of Derycke et al., it can be 
proven that IL-17 can prolong the life of neutrophils in 
non-fibrous nasal polyps where IL-17 can reduce 
apoptosis [23]. In this study, IL-17 was expressed 
primarily by macrophages. IL-17 binds to the IL-17 
receptor with the involvement of tumour necrosis 
factor and receptor factors which activate nuclear 
factor B and subsequently modulate proinflammatory 
cytokines. Jiang et al. explained that interactions 
between IL-17 and IL-17 RD could contribute to the 
growth of nasal polyps, such as thickening of lamina 
basal cells and glandular hyperplasia [24]. 
In this study, the expression of mucosa TGF-
β1 was 24.51 (± 17.03) and in tissues was 85.33% (± 
12.38). Transforming Growth Factor Beta1 is a 
mediator related to tissue remodelling. Transforming 
growth factor-β1 (TGF-β1) is a chemoattractant for 
fibroblasts, stimulating fibroblast proliferation, and 
enhancing collagen laydown by fibroblasts. Of the 
TGF-isoforms, TGF-β1 synthesised by infiltrating 
eosinophils may contribute to stromal fibrosis and 
basement membrane thickening, which are 
characteristic of nasal polyp [25]. Transforming 
Growth Factor Beta1 plays an important role in the 
balance of fibrinolysis and fibrogenesis, which means 
it affects the extracellular matrix. This imbalance is 
Huriyati et al. Association of Inflammation Mediator in Mucosal and Tissue of Chronic Rhinosinusitis with Recurrent Nasal Polyp 
_______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
Open Access Maced J Med Sci.                                                                                                                                                                                                         5 
 
due to the low levels of TGF-β1 in nasal polyps and 
the inhibitory effects on MMP-9 activity through the 
release of TIMP-1 [26]. 
In IL-8, IL-17 and TGF-β1, there was no 
correlation between the expression of cytokines in the 
mucosa and tissue in recurrent CRSwNP, because 
the relationship was not statistically significant (p > 
0.05). The absence of a significant association with IL-
8, IL-17A, TGF-β1 is probably due to the variability of 
the inflammatory expression in nasal polyps. Stevens 
reports that from examining 20 cytokines of 
inflammatory mediators between nasal lavage and 
biopsy tissue of nasal polyps, only IL-10 had a 
significant correlation and positive correlation. This 
finding supports previous observations where there 
was regional variability in the expression of cytokine 
inflammatory mediators in sinonasal cavities [27], [28]. 
Pawankar also explained that the histological 
characteristics of the mucosa and inflammation cells 
of the exudate depend on allergic status [29]. Besides 
of that, in this research, CRSwNP was not 
differentiated based on the dominant histopathological 
type of inflammatory cells, eosinophilic CRSwNP and 
neutrophilic type CRSwNP. Eosinophilic type 
CRSwNP is CRS with a Th2 inflammatory pattern 
where IL-5 is one of the signalling cytokines [30]. 
Neutrophilic type CRSwNP is a polyp which initially 
influenced by infectious factors and commonly found 
in Asian ethnicities. In neutrophilic type CRSwNP, the 
inflammatory pattern that plays a role is Th1 and Th17 
characterised by increased expression of IL-8 and IL-
17A [31]. Also, in this study, the locus of polyp tissue 
sampling could not be taken at the same location for 
each sample.Samplingof tissue polypththe e  could 
not distinguish between the stalk, body (distal, medial 
and proximal) and peak of the polyp. The difference of 
sampling location could make different expression due 
to the discrepancy activity processes in each part of 
the polyp. 
In this study, it was found that only IL-5 has a 
correlation between mucosa and tissue in recurrent 
CRSwNP, we can conclude mucosal brushing 
examination can describe the expression of IL-5 in 
tissues. Further research is needed to find out the 
correlation of cytokine between the mucosa and tissue 
mainly based on the histology type of CRSwNP and to 
look for an easier and more convenient examination 
tool to diagnose recurrent CRSwNP especially at the 
beginning of course of the disease. 
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